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INFECTION RATES IN A TRAUMATIC BRAIN INJURY COHORT TREATED WITH 
INTRAVASCULAR COOLING CATHETERS 
 
Donald T. Schleicher II, M.S. 
University of Pittsburgh, 2008
 
Each year, in the United States, 235,000 individuals sustain a traumatic brain injury 
requiring hospitalization.  Patient outcome from severe traumatic brain injury is improved with 
intensive care management of pathophysiological processes developing in the days following the 
injury.  An important secondary complication of traumatic brain injury is fever, which is known 
to worsen neurologic outcome.  Our institution has recently developed an approach to combat 
fever through the prophylactic use of intravascular cooling catheters, a treatment termed 
controlled normothermia.  
We have recently demonstrated that controlled normothermia reduces both core and brain 
temperature and can improve the intracranial milieu that may facilitate recovery.  A major 
drawback to the systematic use of controlled normothermia is an increased risk of infection, or 
delayed diagnosis of infection by masking of fevers.  In the current study, we evaluated whether 
“controlled normothermia”, the prophylactic use of intravascular cooling catheters in severe 
traumatic brain injury, is associated with increased infection rates during the intensive care stay.    
Utilizing a matched cohort study and data from the Brain Trauma Research Center’s 
database, a retrospective study was performed.  The data was taken from the Brain Trauma 
Research Center’s traumatic brain injury registry, and was matched on age, gender, and Glasgow 
Coma Score.  After analysis, the results of the study indicated fewer infections in the controlled 
 iv 
normothermia group; the rates of bloodstream infections were statistically lower in the controlled 
normothermia group.   
The current study demonstrates that prophylactic use of intravascular cooling catheters in 
severe traumatic brain injury is not associated with an increased risk of infection.  The public 
health significance is that these results lend further support to the concept of controlled 
normothermia as a treatment for severe traumatic brain injury.  Further study may prove that 
controlled normothermia is effective in improving neurologic outcomes from traumatic brain 
injury, which remain the leading cause of death under age 45 in the United States. 
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1.0  INTRODUCTION 
Traumatic brain injury is a major public health concern in the United States.  Each year around 
1.5 million people sustain a traumatic brain injury.  The main mechanisms by which traumatic 
brain injuries occur are through motor vehicle accidents, falls, assaults, motor vehicle versus 
pedestrians, and recreational vehicle accidents.  Each year, of these 1.5 million around 50,000 
people die, either in the hospital or at the scene of the injury, while another 235,000 are 
hospitalized.   
The goal of modern intensive care management of severe traumatic brain injury is to 
minimize secondary complications that may worsen the injury in the days to weeks following the 
traumatic insult.  For example, ischemia following a traumatic brain injury can lead to brain 
tissue receiving inadequate oxygen, further complicating the injury. 
An important secondary complication of traumatic brain injury is fever.  Fever following 
a severe traumatic brain injury can result from multiple etiologies including infection, 
disturbances in the body’s thermo-regulation, or because of drugs administered to patients in the 
intensive care unit.   
Fever control following traumatic brain injuries have long proved difficult.  Historical 
approaches to fever management following traumatic brain injury have produced only moderate 
results at best.  In our institution, a novel approach has been recently adopted in that 
intravascular cooling catheters are placed prophylactically upon admission in an effort to avoid 
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fever and its negative consequences for the already injured brain.  When cooling catheters are 
placed prophylactically, this treatment approach is termed controlled normothermia.  Preliminary 
results indicate that controlled normothermia produces tangible benefits for the patient in the 
form of reduced secondary brain injury and improved temperature control.   
 The purpose of the current study is to evaluate whether the therapeutic approach of 
controlled normothermia is associated with increased rates of nosocomial infections.  
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2.0  RELEVENT LITERATURE REVIEW 
Fever following severe traumatic brain injury occurs frequently in the injured patient, and has 
been associated with worsened neurological outcomes.  Fever occurs in up to 70% of patients 
following severe traumatic brain injury.2  Febrile episodes in the recovering patient can occur in 
multiples and can be of extended duration throughout the patients’ stay in the neurological 
intensive care unit.  
Fever in the neurological intensive care unit is also correlated with length of stay in the 
hospital.  Kilpatrick et al18 reported that 15% of patients in the neurological intensive care unit 
for less than 24 hours suffer from a febrile episode while 93% of patients who remain in the 
intensive care unit for more than 7 days have a febrile episode.  Early hyperthermia (within 48 
hours post injury) is associated with poor outcomes,11 while fever in pediatric traumatic brain 
injury is associated with both longer length of stay in the hospital and poor neurologic outcome. 
26 
Hyperthermia following severe traumatic brain injury may result from both infections 
and non-infectious causes.  Disruption of the hypothalamic set point due to traumatic brain injury 
or intracranial pathologies such as sub-arachnoid hemorrhage or intraparenchymal hemorrhage 
may also induce fever.  Fever may alternatively occur in response to medications or transfusions 
or from atelectasis after surgery, whether surgery is related to the traumatic brain injury or not.   
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Treatment of fever has been correlated with improved outcomes in multiple neurological 
insults.  In the setting of severe traumatic brain injury, fever control has a sound theoretical basis 
for improving outcomes, but this has not yet been demonstrated with a prospective clinical trial. 1   
In the late 1990’s, our institution adopted an aggressive fever management protocol for 
all patients in the neurological intensive care unit with rectal temperatures greater than 38˚C.  
This protocol, involving standing anti-pyretic medications, surface cooling, and gastric ice 
lavage, led to a significant reduction in febrile episodes, but 47% of the patients in the intensive 
care unit continue to develop febrile episodes. 18
In the search for improved fever control, our institution participated in a multi-centre trial 
investigating the utility of an intravascular cooling catheter to treat fever in the neurological 
intensive care unit.  A prospective, randomized controlled trial was performed comparing 
standard fever management (acetaminophen and an external cooling blanket) with intravascular 
cooling catheters.  The intravascular cooling catheter group experienced a 64% reduction in fever 
burden, determined by the time spent febrile (degree hours).  Treatment groups were equivalent 
in rates of infection and use of antibiotics. 10  The study concluded that intravascular cooling 
catheters were superior to conventional means of fever control with risks equivalent to that of a 
central line catheter placement.   
Our institution then began an evaluation of a treatment approach termed controlled 
normothermia.  Controlled normothermia is the prophylactic placement of an intravascular 
cooling catheter at admission to the neurologic intensive care unit in an effort to prevent the 
fever from occurring in the first place, thus reducing or eliminating its detrimental effects.  
Controlled normothermia has been shown to lower intracranial pressure, lower intracranial fever 
burden, and increase brain tissue oxygenation in severe traumatic brain injury. 23   
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A major concern in controlled normothermia is that patients will suffer increased rates of 
nosocomial infections.  The current study examines whether controlled normothermia, the 
prophylactic use of intravascular cooling catheters, is associated with increased rates of 
infections in severe traumatic brain injury patients in the neurologic intensive care unit. 
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3.0  STUDY DESIGN AND METHODOLOGY 
 
The design of this study is a matched cohort study.  A cohort of patients, those with a severe 
traumatic brain injury was examined in two separate groups: patients who received an 
intravascular cooling catheter and patients who had not.  The intravascular cooling patients were 
selected as the “exposed group” in this study and were matched on age, gender, and severity of 
injury via the Glasgow Coma Score with patients who did not receive the intravascular catheter 
treatment.  The two groups were then examined closer to see what infections they contracted and 
at what times.  The infection rates for these two groups were then compared in order to 
determine whether having an intravascular cooling catheter placed leads to a higher incidence of 
infection, specifically bloodstream, respiratory, urinary, cerebral spinal fluid, and deep wound 
infections. 
 All patients examined in this article were under an Institutional Review Board approved 
treatment regimen and data collection protocol.  This approval was through the University of 
Pittsburgh Brain Trauma Research Center.        
The patient cohort under study, those with severe traumatic brain injuries, had 
information previously collected and compiled into a larger database.  The Brain Trauma 
Research Database contains over 750 patients who sustained a severe head injury.  Along with 
the demographic data, a vast quantity of medical data is collected from these patients.  In order to 
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collect this type of data, the patient was informed of the study and granted collection and use of 
this data to the Brain Trauma Research Center.  A copy of the Internal Review Board approved 
consent form is filed under appendix A.  In addition to the consent form, a preliminary data 
collection form is also included under appendix A.   
Forty eight patients were identified who had received intravascular cooling catheters.  
The patients were then matched with corresponding controls based on the patients’ age, gender, 
and severity of injury via the admitting Glasgow Coma Score.  These three factors (age, gender, 
and injury severity) were chosen, because it has been well documented that these three variables 
have a large impact on the outcome of the patient.  Clinical experience has shown that younger 
patients often have better outcomes when faced with a traumatic brain injury than older patients. 
24  It is documented that men often times have better outcomes than females. 24  Injury severity 
measured by GCS, has been widely documented to affect outcomes specifically: the worse a 
patient is initially the lower the GCS and thus the worse the outcome; better GCS scores mean 
less severe injuries and often times, barring complications, better outcomes.  
 Once the age, gender, and injury severity data were obtained for the catheter group, 
another Access search located patients that had similar age, gender and injury severity who did 
not receive the cooling catheters.  By matching exactly on gender, ±2 years for age, and ±1 
Glasgow Point for GCS, these three factors were adequately controlled for in this study.  
Between the two groups, the total number of patients in this study was 96 (48 who received 
cooling catheters and 48 matched on age, gender, and injury severity who did not receive 
catheters).  Three patients and their corresponding controls were removed from the study because 
the exposed patients died within 14 days of admission.   
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After selection of “exposed” and “control” groups, all of the patients’ demographic data 
were entered into a large Excel spreadsheet.  The data that were included in this initial 
spreadsheet were age, injury severity, gender, date of injury, date of hospital admission, death 
date, 14 days post admission, date of catheter insertion, and the date of catheter removal, and 
whether or not the patient had an invasive surgery or a skull fracture.  Once these data were 
obtained, further searches revealed bacterial culture data and other cultures, such as fungal 
infections. 
Another complication that arose from the data is that the catheter insertion time was 
different from the admission time on six of the intravascular patients.  This posed a problem 
because it was unknown as to whether the catheter was placed because a fever was beginning to 
develop.  Either way, the catheter was not inserted prophylactically and thus these six patients 
and their corresponding controls were removed from analysis.  After the removal for death and 
non-prophylactic use, the total population under study is 78 with 39 being patients who received 
an intravascular cooling catheter on admission and 39 who did not, matched on age, gender, and 
injury severity.   
Upon completion of the data collection, Statistical Analysis Software (SAS) performed 
the statistical calculations.   Specifically, the patient characteristics for both the exposed and 
unexposed groups were examined through chi-square analysis for proportions and with 
Wilcoxon Tests for comparison of the means.  Infection outcomes between the two study groups 
were measured with both the chi-square test where applicable, or the Fischer Exact test when 
appropriate.   
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4.0  RESULTS 
The patient population that comprised the cohort under study is summarized in the chart below.  
Figure 1 shows the general overview for the demographics of population under study.   
Table 1: Clinical Cohort Characteristics and Culture Results 
Cohort Characteristics Intravascular Cooling 
Catheters 
n=39 
Non-Intravascular 
Cooling Catheters 
n=39 
Relative 
Risk 
95% Confidence 
Interval 
Gender (Male) 33 33 * p-value .78 
Mean Age (Years) 35.9 35.7 * p-value .85 
Mean GCS 5.9 5.8 * p-value .65 
Invasive Operations 74.4% 76.9% * p-value .79 
Skull Fracture 53.8% 30.8% * p-value .039 
Deep Wound 
Infections 
2.6% 5.1% .51 .05-5.4 
Bronchial Alveolar 
Lavage 
84.6% 71.8% 1.18 .93-1.5 * 
Blood Culture Isolate 35.9% 59% 0.61 .37-.99 * 
Clostridium Difficile 
Toxin 
5.1% 2.6% 2 .19-21.2 
Cerebral Spinal Fluid 
Isolate 
10.3% 10.3% 1 .27-3.7 
Nasal Swab Isolates 2.6% 2.6% 1 .06-15.4 
Vancomycin 
Resistant 
Enterococcus 
2.6% 2.6% 1 .06-15.4 
Sputum Culture 
Isolate 
28.2% 43.60% 0.65 .35-1.2 * 
Catheter Tip Isolate 5.1% 0% Undefined Undefined 
Urine Culture Isolate 15.4% 15.4% 1 .35-2.8 
*  Denotes borderline significance 
 9 
The first step to examining the results was to examine the matching of the two groups to 
confirm that the matching protocol was adequate for the study population.  The main determinant 
to show that age had been adequately controlled for was the mean ages between the two groups.  
The intravascular catheter group had a mean age of 35.9 years while the control group had a 
mean age of 35.7 years.  These two means for the groups were not statistically different.  In 
addition to the t-test, a Wilcoxon two sample test was used.  The p-value for this tested showed 
no statistical difference between the two groups.  Again, the mean GCS for the two groups were 
examined with the results being 5.9 and 5.8 for the catheter group and the control group 
respectively.  In addition to the t-test, a Wilcoxon two sample test was performed on the data.  
The GCS between the two groups proved to be not statistically significant.  Finally, the gender 
confounder was examined.  While female gender was less prevalent than male gender in the two 
groups, the proportion of females in each group is the same (six in each group).   
Once the data were shown to be properly matched, the task of finding statistically 
significant results began.  Two of the more common confounding factors skull fractures and 
surgical operations were examined.  There was a statistically significant difference in skull 
fractures between the catheter group and the control group (p-value .039; 54% vs. 31%), such 
that the catheter group had more skull fractures than the control group.  Since this was a 
clinically relevant and statistically significant confounder, it was adjusted for in the analysis.  
The second potential confounder, the invasive surgical operations, was examined; by both 2x2 
tables and by statistical test, no difference was noted between the two groups.  Since invasive 
surgical operations were not a statistically significant difference between the two groups, an 
invasive surgical procedure is not a strong confounder.  Tables 2 through 4 show final data for 
the outcomes where p-values were less than .20.   
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Table 2: Association between Cooling Catheters and Bronchial Alveolar Lavage Results for All 
Patients 
 Infection Present Infection Absent 
Exposed(normothermia) 33 6 
Control 28 11 
RR=1.18 
p-Value= .22 
 
Table 2 continued: Patients with Skull Fracture 
 Respiratory 
Infection Present
Respiratory 
Infection Absent 
Exposed (normothermia) 18 3 
Control 9 3 
RR=1.14 
 
Table 2 continued: Patients without Skull Fracture 
 Respiratory 
Infection Present 
Respiratory 
Infection Absent 
Exposed (normothermia) 15 3 
Control 19 8 
 RR=1.18 
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Table 3: Association between Cooling Catheters and Blood Culture Results for All Patients 
 Blood Infection 
Present 
Blood Infection 
Absent 
Exposed (normothermia) 14 25 
Control 23 16 
 RR=.61 
 p-Value=.03 
 
Table 3 continued: Patients with Skull Fracture 
 Blood Infection 
Present 
Blood Infection 
Absent 
Exposed (normothermia) 8 13 
Control 8 4 
 RR=.57 
 
Table 3 continued: Patients without Skull Fracture 
 Blood Infection 
Present 
Blood Infection 
Absent 
Exposed (normothermia) 6 12 
Control 15 12 
 RR=.60 
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 Table 4: Association between Cooling Catheters and Sputum Culture Results for All Patients 
 Respiratory 
Infection Present 
Respiratory 
Infection Absent 
Exposed (normothermia) 11 28 
Control 17 22 
 RR=.65 
p-Value=.26 
 
Table 4 continued: Patients with Skull Fracture 
 Respiratory 
Infection Present 
Respiratory 
Infection Absent 
Exposed (normothermia) 3 18 
Control 6 6 
 RR=.29 
Table 4 continued: Patients without Skull Fracture 
 Respiratory 
Infection Present 
Respiratory 
Infection Absent 
Exposed (normothermia) 8 10 
Control 11 16 
 RR=1.09 
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By utilizing two by two tables, the relative risks for each of the three types of cultures are 
calculated.  Utilizing the relative risk allows this paper to justify the risk associated with cooling 
catheter insertion.  Being that skull fracture was a confounding variable, analyses were stratified 
by this factor.  There are no statistically significant differences between the exposure group and 
the unexposed group (p-value >.2) with regard to deep wound infections, clostridium difficile 
isolates, cerebral spinal fluid isolates, methicillan resistant staphylococcus aureus, vancomycin 
resistant enterococcus, catheter tip isolates (either the cooling catheter for the catheter group or a 
central line catheter for the non cooling catheter group), and urine culture isolates.     
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5.0  DISCUSSION 
The present study demonstrates that controlled normothermia, the prophylactic use of 
intravascular cooling catheters to prevent fever, does not increase overall infection rates in 
patients after a severe traumatic brain injury insult.  Furthermore, controlled normothermia is 
associated with a significant decrease in the rates of systemic bacteremia.  Controlled 
normothermia is an effective means of avoiding and treating fever in severe traumatic brain 
injury without an increase in infection rates.   
5.1 INTENSIVE CARE TREATMENT FOR TRAUMATIC BRAIN INJURY 
The goal of intensive care management in the neurologic intensive care unit is to assist the 
patient in achieving the best neurologic and physical outcome.  The goals of effective intensive 
care management include monitoring and treating potential complications that can arise 
throughout the patients’ stay in the hospital.  Some of the complications that can arise are 
increased intracranial pressure, decreased cerebral perfusion, electrolyte imbalance, infections, 
and hyperthermia.   
To combat the negative effects of hyperthermia, the intensive care unit utilizes different 
methods.  Some of the methods include anti-pyretic medications, cooling blankets, and gastric 
ice lavage.  Currently, the neurological intensive care unit in our institution utilizes an aggressive 
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prophylactic catheter-based cooling technique to control the patient temperature.  This treatment 
approach of controlled normothermia, the use of intravascular cooling catheters, is a safe and 
effective means of combating hyperthermia.   
 This new approach, controlled normothermia, is an effective, novel, and innovative 
approach to fever management in the intensive care unit.  The current study examined whether 
controlled normothermia is associated with increased rates of infection in severe traumatic brain 
injury.  The results of the study lend support to the use of controlled normothermia as a fever 
control technique upon admission to the neurologic intensive care unit.    
5.2 INFECTIONS AFTER A SEVERE TRAUMATIC BRAIN INJURY 
Patients suffering from severe traumatic brain injury are at a risk for nosocomial infections 
including respiratory, blood, cerebral spinal fluid, urinary tract, catheter, and wound infections.  
There was no statistically significant findings between the two treatment groups in the 
majority of the culture tests; specifically, the deep wound cultures, the drug resistant strains of 
VRE and MRSA cultures, clostridium difficile toxin screens, the cerebral spinal fluid cultures, 
the urinary cultures and the catheter tip cultures.   
The first objective of this study examined specifically the incidence of infection between 
the treatment and the control groups.  Since many of the cultures were not statistically different 
between the two treatment arms, it can be concluded that the infections rates for these cultures 
did not differ between the two treatment groups.  After analysis, the three cultures that had p-
values lower than .20 were the sputum, the bronchial alveolar lavage, and the blood culture.   
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 The sputum and the bronchial alveolar lavage cultures are respiratory-based cultures and 
are associated strongly with the length of time a patient stays on the ventilator. 5  These 
respiratory infections often do not indicate a systemic infection, but a ventilator-associated 
infection. 5  It can be concluded that these two cultures do not offer significant information as to 
the rates of systemic infection between the two treatment arms.   
 The blood culture data suggest a statistically significant difference between the two 
treatment groups.  The controlled normothermia group had statistically fewer infections when 
compared to the control group.  This observation lends credence to the idea of prophylactic 
treatment with intravascular cooling catheters.  
 The second objective of this study was to examine whether the catheter itself causes an 
increase in infections in the severe traumatic brain injured patient.  By examining the catheter tip 
culture data, it can be seen that, between the two groups, there is no statistically significant 
difference between the controlled normothermia arm and the control arm.  In previous articles, it 
was theorized that the blood circulating around the cooling  catheter would often stagnate around 
the catheter and provide a media for bacterial growth. 10  In addition to the blood stagnation 
around the catheter, the increased lumen size for the intravascular cooling catheter and the 
resulting increased incision could lead to increased infection rates.  The data obtained in this 
study indicate the catheter causes neither a statistically significant increase in the catheter tip 
based infections nor the systemic blood stream infections.  
Prophylactic treatment with intravascular cooling catheters has multiple advantages when 
used in a severe traumatic brain injury patient.  First, the catheters provide optimum environment 
for brain healing by keeping the patient at normothermic levels.  Secondly, the data show that 
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there is not an increased risk for catheter-based infections.  Finally, the rates of systemic blood 
borne infections appear to decrease in the patients treated with intravascular cooling catheters. 
 
5.3 STUDY LIMITATIONS 
        
 
A matched cohort study to examine the effects of intravascular cooling catheters on infection 
rates is an effective method of analysis.  However, as with all studies, this study has limitations 
including small sample size and a retrospective design. 
In addition to the sample size, the study design was retrospective in nature.  It was 
comprised of chart reviews and previously reported data.  This notion can raise a question as to 
the completeness of the data.  The chart reviews were based off billing information.  The billing 
records indicate how many cultures each patient received and even included billing costs for the 
length of time that the intravascular cooling catheter was inserted.  
The final limitation was in the catheter group itself.  When on the intensive care unit, the 
white blood cell count is monitored, along with the fever.  If the patient is unable to develop a 
fever, the infection may be missed by the nursing staff.  This could lead to a lower number of 
cultures in the normothermia group.  This can bias the data by showing an artificial decrease in 
the number of infection in the catheter group.     
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6.0  CONCLUSIONS   
The current study demonstrates that controlled normothermia, the prophylactic use of 
intravascular cooling catheters in severe traumatic brain injury, is not associated with an 
increased risk of infection either from the catheter itself or from the inability to develop a fever.  
Controlled normothermia was associated with a significant decrease in the rates of positive blood 
cultures.  These results lend further support to the concept of controlled normothermia as a valid 
treatment for severe traumatic brain injury.  With this prophylactic treatment, patients can benefit 
from controlled normothermia to provide a better environment conducive to brain healing, 
without the theoretical increased infection risk.   
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